Ontology highlight
ABSTRACT: Background
MicroRNAs (miRNAs) are potential biomarkers for equine sarcoids (ES).Objectives
To assess eca-miR-331, eca-miR-100, and eca-miR-1 as serum biomarkers for ES disease.Animals
Sixty-eight ES cases (56 horses, 12 donkeys), 69 tumor-free controls (60 horses, 9 donkeys), and 20 horses with other skin tumors.Methods
For this case-control study, expression of serum eca-miR-331, eca-miR-100, and eca-miR-1 in ES-affected equids was compared to tumor-free age-, sex-, and breed-matched control horses and donkeys with other skin tumors using reverse transcription quantitative PCR (polymerase chain reaction) for relative miRNA quantification. Biological, preanalytical, and clinical variable influences on miRNA expression were examined. Receiver operator characteristic (ROC) curve analyses were used to determine differences in miRNA expression between groups.Results
The expression of eca-miR-100 was affected by age (P = .003) and expression of eca-miR-100 and eca-miR-1 were affected by hemolysis (both P?Conclusions and clinical importanceSerum eca-miR-331 expression is neither sensitive nor specific enough as a single ES biomarker. If combined with other miRNAs, it may be helpful for ES diagnosis.
SUBMITTER: Unger L
PROVIDER: S-EPMC7848377 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
Unger Lucia L Abril Carlos C Gerber Vinzenz V Jagannathan Vidhya V Koch Christoph C Hamza Eman E
Journal of veterinary internal medicine 20210107 1
<h4>Background</h4>MicroRNAs (miRNAs) are potential biomarkers for equine sarcoids (ES).<h4>Objectives</h4>To assess eca-miR-331, eca-miR-100, and eca-miR-1 as serum biomarkers for ES disease.<h4>Animals</h4>Sixty-eight ES cases (56 horses, 12 donkeys), 69 tumor-free controls (60 horses, 9 donkeys), and 20 horses with other skin tumors.<h4>Methods</h4>For this case-control study, expression of serum eca-miR-331, eca-miR-100, and eca-miR-1 in ES-affected equids was compared to tumor-free age-, se ...[more]